Skip to main content

Advertisement

Table 1 Comparison of KSHV DNA and KSHV seropositivity among 155 HIV-positive incident NHL cases compared to 155 HIV-positive matched controls.

From: Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk

   OR (95% CI)
  N Univariate Multivariate
KSHV serum DNA: ≥1 copy detected 310 2.3 (1.1-5.1) 1.5 (0.53-3.9)
    Among subset with serum within 1 year before diagnosis 130 1.2 (0.37-3.9) 0.81 (0.14-4.7)
    Among subset without Kaposi sarcoma diagnosis 216 4.0 (1.13-14) 1.9 (0.37-9.6)
    Among those developing NHL after AIDS 152 2.0 (0.60-6.6) 2.0 (0.55-7.0)
KSHV antibodies: seroprevalent 252 1.3 (0.68-2.5) 0.85 (0.36-2.0)